Compare $IRON vs $NRIX | Chartloom

Compare

$IRON vs $NRIX

Disc Medicine Inc · Nurix Therapeutics Inc

IRON

Disc Medicine Inc

NRIX

Nurix Therapeutics Inc

Compare $IRON vs $NRIX

Comparing Disc Medicine Inc and Nurix Therapeutics Inc

IRONDisc Medicine Inc

NRIXNurix Therapeutics Inc

IRONDisc Medicine Inc

Market cap

$2.37B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.5%

52W performance

-11.7%

FCF yield

-8.3%

NRIXNurix Therapeutics Inc

Market cap

$2.32B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.84x

Rev growth (TTM)

-58.4%

YTD performance

23.8%

52W performance

123.9%

FCF yield

-13.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IRON

NRIX

Detailed metrics comparison

IRON

Disc Medicine Inc

NRIX

Nurix Therapeutics Inc

Market Cap

IRON$2.37B

NRIX$2.32B

Enterprise Value

IRON$2.33B

NRIX$2.25B

Price

IRON$62.06

NRIX$22.35

P/E Ratio

IRONN/A

NRIXN/A

P/S Ratio

IRON0.00x

NRIX63.09x

EV/Sales

IRON0.00x

NRIX61.25x

EV/EBITDA

IRON0.00x

NRIX0.00x

P/B Ratio

IRON3.84x

NRIX5.93x

P/FCF Ratio

IRONN/A

NRIXN/A

EV/FCF

IRON-11.80x

NRIX-7.39x

PEG Ratio

IRONN/A

NRIXN/A

Forward P/E (NTM)

IRONN/A

NRIXN/A

Forward P/S (NTM)

IRONN/A

NRIX24.84x

Revenue (TTM)

IRON$0

NRIX$37M

Revenue Growth (YoY)

IRONN/A

NRIX-58.4%

Forward Rev Growth

IRON300.5%

NRIX66.6%

Gross Margin (TTM)

IRON0.0%

NRIX0.0%

Operating Margin (TTM)

IRON0.0%

NRIX0.0%

EBITDA Margin (TTM)

IRON0.0%

NRIX-959.0%

Net Margin (TTM)

IRON0.0%

NRIX-928.4%

FCF Margin (TTM)

IRONN/A

NRIX-828.3%

Net Income (TTM)

IRON$-246M

NRIX$-341M

FCF (TTM)

IRON$-198M

NRIX$-305M

EPS (TTM)

IRON-$6.36

NRIX-$3.07

ROE (TTM)

IRON-3717.0%

NRIX-7609.0%

ROA (TTM)

IRON-3365.0%

NRIX-5732.0%

ROIC (TTM)

IRON-3522.0%

NRIX-7609.0%

Cash

IRON$99M

NRIX$68M

Debt

IRON$59M

NRIX$0

Net Cash/Debt

IRON$39M

NRIX$68M

Current Ratio (TTM)

IRON24.14x

NRIX6.34x

Quick Ratio (TTM)

IRON23.64x

NRIX6.16x

Debt/Equity (TTM)

IRON0.09x

NRIX0.00x

Debt/Assets (TTM)

IRON0.0%

NRIX0.0%

Interest Coverage (TTM)

IRONN/A

NRIXN/A

Net Debt/EBITDA (TTM)

IRON0.00x

NRIX0.00x

Beta

IRON0.95

NRIX1.78

52W Performance

IRON-11.7%

NRIX123.9%

YTD Performance

IRON-21.5%

NRIX23.8%

% from 52W High

IRON-37.6%

NRIX-20.8%

% from 52W Low

IRON55.2%

NRIX148.3%

Asset Turnover (TTM)

IRON0.00x

NRIX0.06x

FCF Yield (TTM)

IRON-8.3%

NRIX-13.1%

Earnings Yield (TTM)

IRON-10.4%

NRIX-14.7%

Dividend Yield (TTM)

IRONN/A

NRIXN/A

Rule of 40

IRON0.0

NRIX-886.7

EV/GP/RG

IRONN/A

NRIXN/A

Ticker research

View IRON research View NRIX research

Metric	IRON Disc Medicine Inc	NRIX Nurix Therapeutics Inc
Market & Valuation
Market Cap	$2.37B	$2.32B
Enterprise Value	$2.33B	$2.25B
Price	$62.06	$22.35
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	63.09x
EV/Sales	0.00x	61.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.84x	5.93x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.80x	-7.39x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	24.84x
Revenue & Growth
Revenue (TTM)	$0	$37M
Revenue Growth (YoY)	N/A	-58.4%
Forward Rev Growth	300.5%	66.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-959.0%
Net Margin (TTM)	0.0%	-928.4%
FCF Margin (TTM)	N/A	-828.3%
Net Income (TTM)	$-246M	$-341M
FCF (TTM)	$-198M	$-305M
EPS (TTM)	-$6.36	-$3.07
ROE (TTM)	-3717.0%	-7609.0%
ROA (TTM)	-3365.0%	-5732.0%
ROIC (TTM)	-3522.0%	-7609.0%
Financial Health
Cash	$99M	$68M
Debt	$59M	$0
Net Cash/Debt	$39M	$68M
Current Ratio (TTM)	24.14x	6.34x
Quick Ratio (TTM)	23.64x	6.16x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.95	1.78
52W Performance	-11.7%	123.9%
YTD Performance	-21.5%	23.8%
% from 52W High	-37.6%	-20.8%
% from 52W Low	55.2%	148.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-8.3%	-13.1%
Earnings Yield (TTM)	-10.4%	-14.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-886.7
EV/GP/RG	N/A	N/A
Ticker research	View IRON research	View NRIX research

Valuation

P/S Ratio

IRON

0.00x

NRIX

63.09x

EV/FCF

IRON

-11.80x

NRIX

-7.39x

Growth & revenue

Revenue Growth TTM

NRIX

-58.4%

Forward Revenue Growth

IRON

300.5%

NRIX

66.6%

Profitability & performance

Gross Margin

IRON

0.0%

NRIX

0.0%

ROE

IRON

-3717.0%

NRIX

-7609.0%

FCF Yield %

IRON

-8.3%

NRIX

-13.1%

52-Week Performance

NRIX

123.9%

IRON

-11.7%

Detailed metrics comparison

IRON

Disc Medicine Inc

NRIX

Nurix Therapeutics Inc

Market Cap

IRON$2.37B

NRIX$2.32B

Enterprise Value

IRON$2.33B

NRIX$2.25B

Price

IRON$62.06

NRIX$22.35

P/E Ratio

IRONN/A

NRIXN/A

P/S Ratio

IRON0.00x

NRIX63.09x

EV/Sales

IRON0.00x

NRIX61.25x

EV/EBITDA

IRON0.00x

NRIX0.00x

P/B Ratio

IRON3.84x

NRIX5.93x

P/FCF Ratio

IRONN/A

NRIXN/A

EV/FCF

IRON-11.80x

NRIX-7.39x

PEG Ratio

IRONN/A

NRIXN/A

Forward P/E (NTM)

IRONN/A

NRIXN/A

Forward P/S (NTM)

IRONN/A

NRIX24.84x

Revenue (TTM)

IRON$0

NRIX$37M

Revenue Growth (YoY)

IRONN/A

NRIX-58.4%

Forward Rev Growth

IRON300.5%

NRIX66.6%

Gross Margin (TTM)

IRON0.0%

NRIX0.0%

Operating Margin (TTM)

IRON0.0%

NRIX0.0%

EBITDA Margin (TTM)

IRON0.0%

NRIX-959.0%

Net Margin (TTM)

IRON0.0%

NRIX-928.4%

FCF Margin (TTM)

IRONN/A

NRIX-828.3%

Net Income (TTM)

IRON$-246M

NRIX$-341M

FCF (TTM)

IRON$-198M

NRIX$-305M

EPS (TTM)

IRON-$6.36

NRIX-$3.07

ROE (TTM)

IRON-3717.0%

NRIX-7609.0%

ROA (TTM)

IRON-3365.0%

NRIX-5732.0%

ROIC (TTM)

IRON-3522.0%

NRIX-7609.0%

Cash

IRON$99M

NRIX$68M

Debt

IRON$59M

NRIX$0

Net Cash/Debt

IRON$39M

NRIX$68M

Current Ratio (TTM)

IRON24.14x

NRIX6.34x

Quick Ratio (TTM)

IRON23.64x

NRIX6.16x

Debt/Equity (TTM)

IRON0.09x

NRIX0.00x

Debt/Assets (TTM)

IRON0.0%

NRIX0.0%

Interest Coverage (TTM)

IRONN/A

NRIXN/A

Net Debt/EBITDA (TTM)

IRON0.00x

NRIX0.00x

Beta

IRON0.95

NRIX1.78

52W Performance

IRON-11.7%

NRIX123.9%

YTD Performance

IRON-21.5%

NRIX23.8%

% from 52W High

IRON-37.6%

NRIX-20.8%

% from 52W Low

IRON55.2%

NRIX148.3%

Asset Turnover (TTM)

IRON0.00x

NRIX0.06x

FCF Yield (TTM)

IRON-8.3%

NRIX-13.1%

Earnings Yield (TTM)

IRON-10.4%

NRIX-14.7%

Dividend Yield (TTM)

IRONN/A

NRIXN/A

Rule of 40

IRON0.0

NRIX-886.7

EV/GP/RG

IRONN/A

NRIXN/A

Ticker research

View IRON research View NRIX research

Metric	IRON Disc Medicine Inc	NRIX Nurix Therapeutics Inc
Market & Valuation
Market Cap	$2.37B	$2.32B
Enterprise Value	$2.33B	$2.25B
Price	$62.06	$22.35
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	63.09x
EV/Sales	0.00x	61.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.84x	5.93x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.80x	-7.39x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	24.84x
Revenue & Growth
Revenue (TTM)	$0	$37M
Revenue Growth (YoY)	N/A	-58.4%
Forward Rev Growth	300.5%	66.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-959.0%
Net Margin (TTM)	0.0%	-928.4%
FCF Margin (TTM)	N/A	-828.3%
Net Income (TTM)	$-246M	$-341M
FCF (TTM)	$-198M	$-305M
EPS (TTM)	-$6.36	-$3.07
ROE (TTM)	-3717.0%	-7609.0%
ROA (TTM)	-3365.0%	-5732.0%
ROIC (TTM)	-3522.0%	-7609.0%
Financial Health
Cash	$99M	$68M
Debt	$59M	$0
Net Cash/Debt	$39M	$68M
Current Ratio (TTM)	24.14x	6.34x
Quick Ratio (TTM)	23.64x	6.16x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.95	1.78
52W Performance	-11.7%	123.9%
YTD Performance	-21.5%	23.8%
% from 52W High	-37.6%	-20.8%
% from 52W Low	55.2%	148.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-8.3%	-13.1%
Earnings Yield (TTM)	-10.4%	-14.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-886.7
EV/GP/RG	N/A	N/A
Ticker research	View IRON research	View NRIX research